Skip to main content
. 2020 Oct 14;21(12):1767–1773.e1. doi: 10.1016/j.jamda.2020.10.011

Table 3.

Adjusted HRs (95% CIs) for Mortality and SHRs (95% CIs) for Incident Hospitalization

Mortality (N = 1970)
Hospitalization (n = 1845)
Model 1 Model 2 Model 1 Model 2
SARS-CoV-2 negative 1 (referent) 1 (referent) 1 (referent) 1 (referent)
SARS-CoV-2 positive: 0 symptoms 1.48 (1.03, 2.14) 1.59 (1.10, 2.31) 1.02 (0.79, 1.32) 1.06 (0.82, 1.38)
SARS-CoV-2 positive: 1 symptom 2.86 (1.93, 4.25) 2.92 (1.95, 4.35) 1.75 (1.27, 2.42) 1.69 (1.21, 2.35)
SARS-CoV-2 positive: 2 symptoms 4.35 (2.95, 6.42) 4.44 (2.97, 6.65) 2.39 (1.73, 3.31) 2.38 (1.70, 3.33)

SHR, subhazard ratio.

Death was considered a competing risk for hospitalization models.

Model 1: age, sex, race, facility; model 2: model 1 + asthma, chronic obstructive pulmonary disease or emphysema, cancer, hypertension, atrial fibrillation, coronary artery disease, heart failure, peripheral vascular disease, history of deep vein thrombosis or pulmonary embolus, anemia, diabetes, hypothyroidism, HIV, chronic hepatitis C, cerebrovascular disease, dementia, stage 1-5 chronic kidney disease, end-stage kidney disease, depression, ventilator use, tracheostomy, code status.